Health News Stories

Excerpts of Key Health News Stories in Major Media

Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

For further exploration, delve into our comprehensive Health and Food Corruption Information Center.

Note: This comprehensive list of news stories is usually updated once a week. Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

The combined profits for the ten drug companies in the Fortune 500 ($35.9 billion) were more than the profits for all the other 490 businesses put together ($33.7 billion). Over the past two decades the pharmaceutical industry has moved very far from its original high purpose of discovering and producing useful new drugs. Now primarily a marketing machine to sell drugs of dubious benefit, this industry uses its wealth and power to co-opt every institution that might stand in its way, including the US Congress, the FDA, academic medical centers, and the medical profession itself. The great majority of "new" drugs are not new at all but merely variations of older drugs already on the market. Of the 78 drugs approved by the FDA in 2002, only 17 contained new active ingredients, and only seven of these were classified by the FDA as improvements over older drugs. [The] market would collapse virtually overnight if the FDA made approval of new drugs contingent on their being better in some important way than older drugs already on the market. Many medical schools and teaching hospitals set up "technology transfer" offices to ... capitalize on faculty discoveries. Medical school faculty entered into ... lucrative financial arrangements with drug companies, as did their parent institutions. One of the results has been a growing pro-industry bias in medical research—exactly where such bias doesn't belong. The industry ... fought the state of Maine all the way to the US Supreme Court, which in 2003 upheld Maine's right to bargain with drug companies for lower prices. This industry is taking us for a ride, and there will be no real reform without an aroused and determined public to make it happen.

Note: The above book and book review was written by Dr. Marcia Angell, former editor in chief of the prestigious The New England Journal of Medicine. For more reliable information on the health cover-up, click here.

A research team backed by a federal grant has created a genetically engineered mousepox virus designed to evade vaccines, underscoring biotechnology's deadly potential and stirring debate over whether such research plays into the hands of terrorists. The team at Saint Louis University, led by Mark Buller, created the superbug to figure out how to defeat it. Buller spliced a gene known to suppress the immune system into the mousepox virus, then injected the combined strand into vaccinated mice. All of them died. The research highlights a contentious discussion among scientists and security experts: Does publication of such work help or hinder the biodefense effort? Should such studies be conducted at all? When Buller presented his results last week at an international biodefense conference, it prompted debate. Some feared that publication of such information, regardless of whether scientists' intentions are altruistic, could help terrorists create biological weapons laced with genetically modified superbugs. Such germs are created by splicing drug-resistant genes in viruses normally defeated by vaccines. Alibek, a director of George Mason University's National Center for Biodefense, believes Buller's work and similar research should be confidential to impede terrorists and rogue nations from acquiring knowledge about genetically engineered bioweapons. Buller counters that publicizing such work will deter terrorists by showing that scientists can build defenses against souped-up bioweapons. Buller also believes scientists must genetically engineer pathogens to understand how to defeat them.

Two UK-based academics have devised a way to invent new medicines and get them to market at a fraction of the cost charged by big drug companies. Sunil Shaunak, professor of infectious diseases at Imperial College ... calls their revolutionary new model "ethical pharmaceuticals". Improvements they devise to the molecular structure of an existing, expensive drug turn it technically into a new medicine which is no longer under a 20-year patent to a multinational drug company and can be made and sold cheaply. The process has the potential to undermine the monopoly of the big drug companies and bring cheaper drugs not only to poor countries but back to the UK. Professor Shaunak and his colleague from the London School of Pharmacy, Steve Brocchini, have linked up with an Indian biotech company which will manufacture the first drug - for hepatitis C. Hepatitis C affects 170 million people worldwide and at least 200,000 in the UK. Multinational drug companies put the cost of the research and development of a new drug at $800m (Ł408m). Professors Shaunak and Brocchini say the cost of theirs will be only a few million pounds. Professor Shaunak says it is time that the monopoly on drug invention and production by multinational corporations - which charge high prices because they need to make big profits for their shareholders - was broken. The team's work on the hepatitis C drug has impeccable establishment credentials. But the professors' ethical pharmaceutical model is unlikely to find much favour with the multinational pharmaceutical companies, which already employ large teams of lawyers to defend the patents which they describe as the lifeblood of the industry.

Note: This is very exciting news, but we'll see what happens when the hugely profitable pharmaceutical industry presses its might against this effort. For more, click here.

[Book Review of] Medical Apartheid: The Dark History of Medical Experimentation on Black Americans From Colonial Times to the Present. Harriet Washington opens the door on the torture room in "Medical Apartheid". Experimental operations on the skulls of slave children, Washington writes, were a favorite pursuit of a particularly sadistic South Carolinian doctor named J. Marion Sims, widely revered today as the "father of gynecology." For years, Sims experimented on a group of slave women, to whom he refused anesthesia. The most notorious post-slavery racial crime of American medicine [was] the Tuskegee Syphilis Study, conducted by the U.S. Public Health Service between 1932 and 1972. More than 100 black subjects ... were denied treatment, even and especially after the discovery of penicillin in 1943. The research required that they suffer and die, the more slowly the better. Tuskegee was hardly unique. The Rockefeller Institute ... conducted a study in 1910 that saw 470 black syphilitics injected with a deadly strain of malaria. Black Americans were also disproportionately used ... as subjects in government inquiries into the effects of radiation. Washington's chilling history ends with contemporary case studies. At the Incarnation Children's Center in New York, Columbia University doctors continue to administer experimental AIDS drugs to minority orphans, even after many develop painful and debilitating reactions. As for current clinical trials in Africa, Washington describes the continent as the new "laboratory for the West," where unsuspecting patients regularly receive experimental therapies that might never receive state sanction in the United States or Europe.

Note: For more reliable, verifiable information on major corruption in the health industry, click here. It's also interesting to not that no other major media chose to review this important book.

No one foresaw ... the shocking extent to which the internet would change the terms of trade between corporations and society. One of the world's largest drug companies [was] the first victim. Britain's GlaxoSmithKline, the world's second-largest pharma, denied any wrongdoing, but agreed to pay $2.5m ... for concealing evidence of its antidepressant Seroxat's potential for harming children, while doing them no measurable good. Infinitely more frightening ... this pharma had the backing of institutions that we, the public, rely on to protect us from poisoning by prescription. The Royal College of Psychiatrists had insisted only a year earlier that 'there is no evidence that antidepressant drugs can cause dependence syndromes'. It was really the internet that allowed public health activists to do an end run around GSK's and the medical authorities' denials of the drug's risks. An explosion of websites dedicated to vivid accounts of antidepressant reactions told these campaigners about hundreds of thousands affected by a problem that officially did not exist. Health activists in Britain and America have uncovered the core of pharma might. In both countries, clinical drug tests are paid for by the pharmas, who tweak the trials' design for the best possible results. Until recently, only the most favourable findings got published in the 20,000-odd biomedical journals, many of them dependent on pharmas for funding. The drugs are approved for marketing by regulators, whose salaries are mostly financed by the subjects of their evaluations. The medicines are then prescribed by doctors routinely courted with pharma gifts ... meant to persuade them to change their prescribing habits.

Note: For a two-page summary with lots more reliable information on major health cover-ups by a doctor who was editor-in-chief of one of the most pretigious medical journals in the world, click here.

Consumer advocates and others have complained bitterly in recent years that the Food and Drug Administration has veered from its scientific roots. Later this week, the agency is expected to release a formal recommendation that milk and meat from cloned animals should be allowed on grocery store shelves. The long-awaited decision comes as polling data to be released this week show that the public continues to have little appetite for such food, with many people saying the FDA should keep it off the market. That raises the issue: Should decisions such as this one be based solely on science, or should officials take into account public sensitivities, which may be unscientific but are undeniably real? "There is more to this issue than just food safety," said Susan Ruland of the International Dairy Foods Association, which represents such major companies as Kraft Foods and Dannon. The organization's member companies are concerned that sales of U.S. dairy products could drop by 15 percent or more if the FDA allows the sale of meat and milk from clones. Relatively few cloned farm animals exist; there are an estimated 150 clones out of the nation's 9 million dairy cows. But biotechnology companies are gearing up to clone farmers' tastiest cattle and pigs and most productive dairy cows. In the University of Maryland survey, nearly half of those polled asserted that it was not yet possible to clone farm animals for food. For the most part, people don't know this is a reality yet.

A Toronto-led team of researchers has discovered a trigger for Type 1 diabetes, a breakthrough that has long evaded scientists and could lead the way to preventing the disease. The team found that abnormal nerve endings in the insulin-producing cells of the pancreas initiated a chain of events that caused Type 1 diabetes in mice. When they removed the nerve cells, the mice did not develop the disorder. That means diabetes may be a disease of the nervous system, not just an autoimmune disease, said Dr. Hans Michael Dosch, a senior scientist at the Hospital for Sick Children and the study's main investigator. In a reversal of what they expected, the researchers also found injecting substance P — a chemical secreted by nerve cells — into mice whose islet cells were inflamed and on the way to being destroyed not only eliminated the inflammation but reversed it. "The blood glucose normalizes overnight and it stays low for weeks to months — this is with a single shot," Dosch said. "We now have 4-month-old mice that are non-diabetic that used to be diabetic" — a period equivalent to six to eight years in humans. Experts say the findings, reported yesterday in the journal Cell, will change the way scientists think about diabetes. "It really is a breakthrough for the diabetes community," said Pam Ohashi, a professor of immunology at the University of Toronto. Dosch has immediate plans to move his research from mice to humans. He is launching a clinical trial in January to figure out if patients who have a high risk of Type 1 diabetes have the same sensory nerve abnormalities. "If they do, then we have fantastic new therapeutic strategies," said Dosch, who is also a professor of pediatrics and immunology at U of T.

Note: The pharmaceutical industry makes huge profits from diabetics. Big profits have been known to prevent cures from making it to market. Click here for more. Let's hope this important research moves forward.

Some 10,000 US researchers have signed a statement protesting about political interference in the scientific process. The statement, which includes the backing of 52 Nobel Laureates, demands a restoration of scientific integrity in government policy. According to the American Union of Concerned Scientists, data is being misrepresented for political reasons. It claims scientists working for federal agencies have been asked to change data to fit policy initiatives. The Union has released an "A to Z" guide that ... documents dozens of recent allegations involving censorship and political interference in federal science. Campaigners say that in recent years the White House has been able to censor the work of agencies like the Environmental Protection Agency and the Food and Drug Administration because a Republican congress has been loath to stand up for scientific integrity. Michael Halpern from the UCS said the statement of objection to political interference had been supported by researchers regardless of their political views. "This science statement that has now been signed by the 10,000 scientists is signed by science advisers to both Republican and Democratic administrations dating back to President Eisenhower, stating that this is not business as usual and calling for this practice to stop."

One hundred years ago, companies were free to follow their own rules. The publication of Upton Sinclair’s novel “The Jungle” in 1906 — with its descriptions of rat-infested slaughterhouses and rancid meat — created public outrage over food safety. Even though the book was written by a socialist agitator, a Republican president, Theodore Roosevelt, eagerly read it. After confirming Sinclair’s claims, Roosevelt battled the drug companies, the big food processors and the meatpacking companies to protect American consumers from irresponsible corporate behavior. Over the past 40 years, the industrialization and centralization of our food system has greatly magnified the potential for big outbreaks. As a result, a little contamination can go a long way. The Taco Bell distribution center in New Jersey now being investigated as a possible source of E. coli supplies more than 1,100 restaurants in the Northeast. Since 2000, the fast-food and meatpacking industries have given about four-fifths of their political donations to Republican candidates for national office. In return, these industries have effectively been given control of the agencies created to regulate them. The current chief of staff at the Agriculture Department used to be the beef industry’s chief lobbyist. The person who headed the Food and Drug Administration until recently used to be an executive at the National Food Processors Association. Cutbacks in staff and budgets have reduced the number of food-safety inspections conducted by the F.D.A. to about 3,400 a year — from 35,000 in the 1970s.

Note: If you care about the health of our nation's food supply, write your political and media representatives encouraging the passage of the Safe Food Act mentioned in this article, which by the way, was written by the author of the most excellent book, Fast Food America.

The scientist who first linked smoking to lung cancer was [later] paid by a chemicals firm while investigating cancer risks in the industry. Professor Sir Richard Doll held a consultancy post with US firm Monsanto for more than 20 years. The BBC has seen private letters which show that Sir Richard ... received a US$1,500-a-day consultancy fee from Monsanto in the mid-1980s. During that time he investigated the potential cancer causing properties of the powerful herbicide Agent Orange, made by the company. Sir Richard [argued] that there was no evidence that Agent Orange caused cancer. Professor Lennart Hardell, of the Oncology Department at University Hospital Orebro, Sweden, has also studied the potential hazards posed by Agent Orange. He was one of the scientists whose work was dismissed by Sir Richard. He said: "It's quite OK to have contacts with industry, but you should be fair and say 'well, I'm [working] as a consultant for Monsanto." Further documents obtained by The Guardian newspaper allegedly show that Sir Richard was also paid a Ł15,000 fee by the Chemical Manufacturers Association, and chemicals companies Dow Chemicals and ICI for a review of vinyl chloride, used in plastics, which largely cleared the chemical of any link with cancers apart from liver cancer. Sir Richard's views on the chemical were used by the manufacturers' trade association to defend it for more than a decade.

Jerry Wheat and the other Gulf vets were never told of the risks of being exposed to a DU campaign. Awarded a Purple Heart after being wounded in combat, Wheat came home with pieces of shrapnel embedded in his body and with mysterious body pains. A year after war's end, Wheat got startling evidence from his father -- a technician at the famous Los Alamos Nuclear Research Centre, who just out of curiosity tested the shrapnel that came from his son's body and gear. The shrapnel was radioactive. Today, eight years after the Gulf War, that shrapnel still lights up a Geiger counter. Jerry's great fear is that whatever he brought back with him from the Gulf is now afflicting his family. His older son Joe was hospitalized with breathing problems the day after Wheat dragged his contaminated gear into the house. Derrick, his youngest son, who was born after the war, suffers strange blisters on his hands. His wife suffered a miscarriage. Jerry himself recently had a tumour removed from his shoulder. He now worries continually about cancer. Jerry says the military has never shown any interest in his shrapnel. The military said Jerry's health problems are due to post traumatic stress. If the lessons from past eras are anything to go by, there is often great ignorance about the path being charted when new weapons come along. For example when atomic testing was all the rage in the '50s, or when Agent Orange was used in Vietnam. When revolutionary new technology is introduced on the battlefield, no one at the time has any real idea of the consequences.

Note: BBC has a webpage listing 10 of their articles both pro and con regarding depleted uranium at http://news.bbc.co.uk/2/hi/in_depth/europe/2001/depleted_uranium/default.stm

Between 1999 and 2001, unbeknownst to the others, each [of four scientists] made a simple but dramatic discovery that challenged the catechism of the same powerful industry -- biotechnology -- that by then had become the handmaiden of industrial agriculture and the darling of venture capitalists. When he was the principal scientific officer of the Rowett Institute in Aberdeen, Scotland, Hungarian citizen Arpad Pusztai fed transgenically modified [GMO] potatoes to rodents in one of the few experiments that have ever tested the safety of genetically modified food. Almost immediately, the rats displayed tissue and immunological damage. After he reported his findings, which eventually underwent peer review and were published in the United Kingdom's leading medical journal, Lancet, Pusztai's home was burglarized and his research files taken. Soon thereafter, he was fired from his job at Rowett, and he has since suffered an orchestrated international campaign of discreditation. [Read full article for the other three distrubing stories of scientific suppression] These four men were not attacked because of flawed or imperfect experiments but because the findings of their work have a potential economic effect. The sad part is that the academies and other allegedly independent institutions that once defended scientific freedom and protected employees like Hayes, Chapela, Losey and Pusztai are abandoning them to the wolves of commerce, the brands of which are being engraved over the entrances to a disturbing number of university labs.

Note: Big money is clearly stifling good science and keeping the public in the dark about genetic modifications in the food we eat. To educate yourself on this most important topic, click here.

When the drug industry came under fire last summer for failing to disclose poor results from studies of antidepressants, major drug makers promised to provide more information about their research on new medicines. But nearly a year later, crucial facts about many clinical trials remain hidden. Eli Lilly and some other companies have posted hundreds of trial results on the Web and pledged to disclose all results for all drugs they sell. But other drug makers, including Merck and Pfizer, release less information and are reluctant to add more, citing competitive pressures. As a result, doctors and patients lack critical information about important drugs ... and the companies can hide negative trial results by refusing to publish studies, or by cherry-picking and highlighting the most favorable data. GlaxoSmithKline agreed to pay $2.5 million to settle a suit ... alleging that Glaxo had hidden results from trials showing that its antidepressant Paxil might increase suicidal thoughts in children and teenagers. Federal laws require the disclosure of all trials and trial results to the F.D.A. But companies are not required to disclose trial results to scientists or the public. Under pressure from the editors of medical journals, the major drug companies in January agreed to expand the number of trials registered on clinicaltrials.gov. Three companies have filed only vague descriptions of many studies, often failing even to name the drugs under investigation. For example, Merck describes one trial as a "one-year study of an investigational drug in obese patients."

In Minnesota, pigs are being born with human blood in their veins. In Nevada, there are sheep whose livers and hearts are largely human. In California, mice peer from their cages with human brain cells firing inside their skulls. Biologists call these hybrid animals chimeras, after the mythical Greek creature with a lion's head, a goat's body and a serpent's tail. Chimeras are allowing scientists to watch, for the first time, how nascent human cells and organs mature and interact ... inside the bodies of living creatures. But with no federal guidelines in place ... how human must a chimera be before more stringent research rules should kick in? Chimerism becomes a more sensitive topic when it involves growing entire human organs inside animals. And it becomes especially sensitive when it deals in brain cells. Imagine, said Robert Streiffer, a professor of philosophy and bioethics at the University of Wisconsin, a human-chimpanzee chimera endowed with speech ... what some have called a "humanzee." Perhaps the most ambitious efforts to make use of chimeras come from Irving Weissman, director of Stanford University's Institute of Cancer/Stem Cell Biology and Medicine. Weissman helped make the first mouse with a nearly complete human immune system. More recently his team injected human neural stem cells into mouse fetuses, creating mice whose brains are about 1 percent human. Now Weissman says he is thinking about making chimeric mice whose brains are 100 percent human.

Note: If the above link fails, click here.

An ancient native American treatment for cancer has been shown to have a beneficial effect despite scepticism from the medical establishment. Chaparral, an evergreen desert shrub, has long been used by native Americans to treat cancer, colds, wounds, bronchitis, warts, and ringworm. But experts dismissed its worth, and warned it could be dangerous. Now researchers at the Medical University of South Carolina have shown an extract may shrink some tumours. Chaparral tea was widely used in the US as an alternative anti-cancer agent from the late 1950s to the 1970s. However, the American Cancer Society said there was no proof that it was an effective treatment for cancer - or any other disease. And the US Food and Drug Administration warned against its use after research showed it could damage the liver and the kidneys. However, initial results from the latest study show that an extract of the shrub appears not only to be safe, but to have a positive effect. The researchers tested a refined extract taken from chaparral called M4N. They injected it into the tumours of eight patients with advanced head and neck cancer that had not responded to other forms of treatment. The results were encouraging - patients seemed to tolerate it well, and there was no evidence of the serious liver damage previously associated with chaparral use. The study also produced some evidence that the extract had begun to shrink the tumours.

Note: Some believe that because cancer treatment brings huge profits, viable treatments which are inexpensive are strongly suppressed. For reliable evidence on this, click here and here.

Hundreds of mentally ill patients who were subjected to barbaric CIA-funded brainwashing experiments ... could be entitled to compensation following a landmark court ruling. Doctor Ewan Cameron, who became one of the world’s leading psychiatrists, developed techniques used by Nazi scientists to wipe out the existing personalities of people in his care. Cameron ... was recruited by the CIA during the cold war while working at McGill University in Montreal, Canada. He carried out mind-control experiments using drugs such as LSD on hundreds of patients, but only 77 of them were awarded compensation. Now a landmark ruling by a Federal Court judge in Montreal will allow more than 250 former patients, whose claims were rejected, to seek compensation. Last week, Alan Stein, of Montreal law firm Stein and Stein ... confirmed he was in the process of contacting former clients who could now renew their appeal. “There are about 200 people still due compensation,” he said. Using techniques similar to those portrayed in the celebrated novel the Manchurian Candidate, it was believed that people could be brainwashed and reprogrammed to carry out specific acts. Cameron developed a range of depatterning “treatments”. Patients were woken from drug-induced stupors two or three times a day for multiple electric shocks. In a specially designed “sleep room” made famous by Anne Collins’s book of the same name, Cameron placed a speaker under the patient’s pillow and relayed negative messages for 16 hours a day. Cameron ... rose to become the first president of the World Psychiatric Association.

Note: If the above link does not work, click here. Dr. Cameron was once President of the American and World Psychiatric Associations. For more on the severe abuses of doctors in serving the CIA's mind control programs, click here. This article clearly shows that the Manchurian candidate (programmed assassin) is not just fiction. For a powerful two-page summary of 18,000 pages of declassified CIA documents on this disturbing mind control program, click here. Links to view the original top secret documents are included.

Federal health officials won’t put new restrictions on the use of a mercury-based preservative in vaccines and other medicines. A group called the Coalition for Mercury-free Drugs petitioned the Food and Drug Administration in 2004 seeking the restrictions on thimerosal, citing concerns that the preservative is linked to autism. The FDA rejected the petition. Thimerosal, about 50 percent mercury by weight, has been used since the 1930s to kill microbes in vaccines. There have been suspicions that thimerosal causes autism. However, studies that tracked thousands of children consistently have found no association between the brain disorder and the mercury-based preservative. Critics contend the studies are flawed. Since 2001, all vaccines given to children 6 and younger have been either thimerosal-free or contained only trace amounts of the preservative. Thimerosal has been phased out of some, but not all, adult vaccines as well. Most doses of the flu vaccine still contain thimerosal. There also are minute amounts of mercury, as thimerosal or phenylmercuric acetate, in roughly 45 eye ointments, nasal sprays and nasal solutions, the FDA said.

Note: Why are they still using mercury in flu shots when it is not necessary? Heavy metals are well known to be toxic to the human body. The studies mentioned above are almost entirely funded by pharmaceutical interests and government bodies working with them. For lots more on this major cover-up, click here.

Federal health officials have decided to forgo gathering detailed data on whether children in 22 big cities are receiving recommended immunizations and instead will survey teenagers, who are the target of several new vaccines. The decision is drawing protests from local health officials, who say the soon-to-be-lost information is essential to their efforts to make sure that infants and toddlers, many from poor families, are protected against childhood infections. Each year, the CDC contracts a polling company to get data on vaccination rates in various age, demographic and income groups nationwide. "We need to know if the new vaccine has helped, or had no change, or hurt [coverage], and we cannot really make those judgments without the NIS data," [one health official] said. CDC officials said they are redirecting about $3 million to survey adolescents. The only way to pay for the 22-city sampling would be to use money now used to help states buy vaccine, they added. The decision comes at a time when the government is spending record amounts on public health. The CDC's budget has risen 42 percent since 2001 and is now $8.73 billion.

Note: This unusual decision makes sense if you consider that the powerful pharmaceutical industry doesn't want tracking on toddler vaccinations, as it may show what they have long denied -- that there is a link between autism and childhood vaccinations. The mercury-derivative Thimerosal was largely taken out of childhood vaccinations just a few years ago. The much-awaited data needed to prove or disprove a link will now be more difficult to obtain.

Hoping to prevent Congress from letting the government negotiate lower drug prices for millions of older Americans on Medicare, the pharmaceutical companies have been recruiting Democratic lobbyists [and] lining up allies in the Bush administration and Congress. Many drug company lobbyists concede that the House is likely to pass a bill intended to drive down drug prices, but they are determined to block such legislation in the Senate. If that strategy fails, they are counting on President Bush to veto any bill that passes. With 49 Republicans in the Senate next year, the industry is confident that it can round up the 34 votes normally needed to uphold a veto. They began developing strategy last week at a meeting of the board of the Pharmaceutical Research and Manufacturers of America. Billy Tauzin, president of that group [and] a former congressman...met with Senator Byron L. Dorgan, a North Dakota Democrat who has been trying for six years to allow drug imports from Canada. The industry vehemently opposes such legislation. The 2003 Medicare law prohibits the federal government from negotiating drug prices or establishing a list of preferred drugs. Drug makers have not set a budget for their campaign. They and their trade groups already spend some $100 million a year on lobbying in Washington. Representative Frank Pallone Jr., Democrat of New Jersey [said] “The 2003 Medicare law was essentially written by the drug industry.” Drug companies may be open to some changes in the Medicare drug benefit, but they say they cannot accept any form of price negotiation.

Note: For lots of verifiable information on the power of the drug industry to corrupt Congress, click here.

The Department of Agriculture declared safe for human consumption yesterday an experimental variety of genetically engineered rice found to have contaminated the U.S. rice supply this summer. The move ... to deregulate the special long-grain rice, LL601, was seen as a legal boon to its creator, Bayer CropScience. The company applied for approval shortly after the widespread contamination was disclosed in August and now faces a class-action lawsuit filed by hundreds of farmers in Arkansas and Missouri. The experimental rice ... escaped from Bayer's test plots after the company dropped the project in 2001. The resulting contamination, once it became public, prompted countries around the world to block rice imports from the United States, sending rice futures plummeting and farmers into fits. In approving the rice, the USDA allowed Bayer to take a regulatory shortcut and skip many of the usual safety tests. Joseph Mendelson, legal director of the nonprofit Center for Food Safety, said the quick approval shows that the USDA is more concerned about the fortunes of the biotechnology industry than about consumers' health. "USDA is telling agricultural biotechnology companies that it doesn't matter if you're negligent, if you break the rules, if you contaminate the food supply with untested genetically engineered crops, we'll bail you out," Mendelson said in a statement. Officials in Europe, where genetically altered rice is derisively dubbed "Frankenfood," made clear as recently as last week that European countries will not accept any U.S. rice, he said.

Note: For reliable information on the deception and dangers of GM (Genetically Modified) food, click here.

Important Note: Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.